Definitive Contract 75N91022C00015
Award Date
9/16/22
Potential Completion Date
9/15/25
Potential Value
$2M
Federal Agency
National Cancer Institute
Awardee
Cellsight Technologies, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94107, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $247,568 Firm Fixed Price contract awarded by the National Cancer Institute (NCI) to Cellsight Technologies, Inc., a woman-owned small business. The contract is for research and development related to a novel PET imaging agent, [18F]F-ARAG, to assess response to cancer immunotherapies. This contract is part of NCI's Small Business Innovation Research (SBIR) program, which sets aside certain research and development contracts for small businesses. Cellsight Technologies has also...
This is a $300,000 Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute (NCI) to Cellsight Technologies, Inc., a woman-owned small business, under the Small Business Innovation Research (SBIR) program. The purpose of the contract is to evaluate [18F]F-ARAG, a T cell-specific Positron Emission Tomography (PET) imaging agent, as a biomarker to predict response to cancer immunotherapies. This Phase I SBIR contract builds on a previous $2 million...
This is a $299,640.99 Firm Fixed Price contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Cellsight Technologies, Inc. The contract is for research and development services related to a noninvasive PET imaging strategy for longitudinal monitoring of the tumor microenvironment, under the Small Business Innovation Research (SBIR) program. The contract was set aside for small business participation. Cellsight Technologies, Inc....
This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
This is a $189,094.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Angiocrine Bioscience, Inc., a for-profit organization. The contract is for the "SBIR PHASE I LARGE SCALE PROPAGATION OF CANCER CELLS USING THE VERAVEC PLATFORM IN AN AUTOMATED CLOSED SYSTEM" and was set aside for small businesses. The contract has an ultimate completion date of July 21, 2016 and was awarded on September 22, 2015. This appears to be a Small Business...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
<p>This is a $1,908,932.02 Firm Fixed Price Definitive Contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Photolitec LLC, a small business limited liability company, for SBIR Phase II research on image-guided photodynamic therapy in combination with chemotherapy for lung cancer treatment. The contract was set aside for Total Small Business and has a completion date of February 18, 2022.</p>
This is a $1,998,978.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian federal agency, to Light Research Inc., a for-profit small business. The contract is for Phase 2 of a Small Business Innovation Research (SBIR) program, under Topic 431 "LIGHT RESEARCH". The contract has a Total Small Business set-aside and an ultimate completion date of September 15, 2026. Light Research Inc. is a small business that provides research, development, and...